Current Biology of MTP: Implications for Selective Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|5|3|283-300

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.3, 2005-04, pp. : 283-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?

By Burnett John R   Watts Gerald F  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 181-189

Informa Healthcare

Access to resources Recommend Favorite

Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine: A New Therapeutic Perspective in Cardiovascular Disease

By Dario DiFrancesco  

Drugs, Vol. 64, Iss. 16, 2004-01 ,pp. : 1757-1765

Adis International

Access to resources Recommend Favorite

Clinical Pharmacology of If Current Inhibition

By  

Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. : 21-24

Karger

Access to resources Recommend Favorite

Selective Raf inhibition in cancer therapy

By Khazak Vladimir   Astsaturov Igor   Serebriiskii Ilya G   Golemis Erica A  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1587-1609

Informa Healthcare

Access to resources Recommend Favorite

Selective Cyclooxygenase Inhibitors: Current Status

By  

Current Drug Discovery Technologies, Vol. 11, Iss. 2, 2014-06 ,pp. : 127-132

Bentham Science Publishers

Access to resources Recommend Favorite